The European Medicines Agency and the European pharmaceutical industry federation EFPIA have asked companies to identify any potential vaccines or treatments they may have in their back catalogues that could be useful in tackling the ongoing novel coronavirus outbreak.
The European Commission is also offering emergency funding for research into better understanding the characteristics of 2019-nCoV and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?